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Autophagy is an evolutionarily conserved pathway that is responsible for the turnover of 
non-essential proteins and organelles during periods of nutrient limitation or stress.  The 
products of this process are recycled and used for the synthesis of the macromolecules 
needed for survival. The autophagy process is being considered as a point of therapeutic 
intervention in many diseases including many cancers and neurodegenerative disorders, 
like Huntington’s disease. It is therefore critical that we develop a thorough 
understanding of autophagy regulation. Toward this end, my work has focused on the 
Atg1 protein kinase, a key point of regulatory control within this pathway in all 
eukaryotes.  Atg1 is targeted by a number of signaling pathways that are responsible for 
coordinating growth with nutrient availability.  My studies were focused on developing a 
better understanding of how these pathways influence autophagy by controlling the 
phosphorylation status of Atg1. In particular, we used mass spectrometry (MS) to identify 
candidate phosphorylation sites on Atg1 and then assessed the physiological significance 
of these sites for autophagy in Saccharomyces cerevisiae. Site-directed mutagenesis was 
used to individually replace different serine (or threonine) residues that were normally 
phosphorylated with either a nonphosphorylatable alanine or a phosphomimetic (e.g. 
glutamic acid). These studies identified Thr-226 phosphorylation within the Atg1 
activation loop as a positive regulator of both Atg1 kinase activity and autophagy.  A 
number of other mutants analyzed demonstrated a modest decrease in autophagy. These 
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 Autophagy is a highly conserved degradative pathway that non-specifically 
engulfs portions of the cytoplasm during periods of nutrient limitation (Tsukada and 
Ohsumi 1993). At the pre-autophagosomal structure (PAS), a double-membrane 
surrounds proteins and other components within the cytoplasm to form an 
autophagosome (Suzuki and Ohsumi 2007). This autophagosome is targeted to the 
lysosome in mammalian cells or the vacuole in yeasts (Xie and Klionsky 2007).  The 
encapsulated macromolecules are then broken down into their constituent components, 
which are reused by the cell to allow for their survival during this period of stress. 
 Autophagy has been linked to a wide variety of human ailments, including 
cancers and neurodegenerative diseases. Depending on the type of cancer, autophagy has 
been found to either promote or inhibit tumor progression.  For example, cancerous cells 
divide uncontrollably to form tumors even when there are not enough nutrients to sustain 
the aberrant growth. Autophagy helps to maintain these cancerous cells because they are 
able to reuse their own components to continue living before angiogenesis within the 
tumor (Levine and Kroemer, 2008). In contrast, autophagy may contribute to specific 
programmed cell deaths and the inactivation of autophagy has been implicated in the 
progression of specific cancers, including breast and ovarian cancers (Chen et al. 2009). 
Also, autophagy inhibits neurodegenerative disorders like Alzheimer’s and Huntington’s 
disease, which are associated with the accumulation of toxic aggregates of certain 
proteins in the neurons of the afflicted brains. Autophagy strives to recycle these 
aggregates so that they do not increase to toxic levels (Levine and Kroemer, 2008). Thus, 
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there has been tremendous interest in manipulating autophagy as a possible means of 
therapeutic intervention for these diseases. This objective in turn necessitates a more 
complete understanding of the activation and regulation of autophagy, the central focus 
of this work. 
 Autophagy has been conserved through evolution, from single-celled yeasts to 
humans. In fact, most of our knowledge of this process comes from work on 
Saccharomyces cerevisiae, bakers’ yeast. In yeast, over 30 Atg proteins are involved in 
autophagy, and most of them have functional counterparts in human cells (Meijer et al. 
2007; Tsukada and Ohsumi 1993). Atg1 is a serine/threonine-specific protein kinase, 
whose activity is required for the induction of autophagy.  Atg1, and its associated 
proteins, form a complex that appears to be a key point of regulatory control for the 
autophagy process (Budovskaya et al. 2005; He and Klionsky 2009; Kamada et al. 2000; 
Stephan et al. 2009).  In particular, both Atg13 and Atg17 are required for Atg1 kinase 
activity and are found in this complex necessary for the autophagy process (Kamada et 
al. 2000; Stephan et al. 2009). 
Protein phosphorylation is a major post-translational modification used to regulate 
many biological processes, including the autophagy pathway. Recent studies have 
demonstrated that two major signaling pathways required for the proper control of S. 
cerevisiae growth directly target components within the Atg1 complex and thereby 
inhibit the autophagy process. The Tor protein kinase directly phosphorylates Atg13 and 
the cAMP-dependent protein kinase modifies both Atg1 and Atg13 in vivo. Each of these 
modifications has been shown to interfere with the assembly of the Atg1 complex in S. 
cerevisiae (Budocskaya et al. 2004; Kamada et al. 2010; Noda and Ohsumi 1998; 
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Stephan et al.  2009).  I found that within the Atg1 kinase domain, Thr-226 is an 
important site of regulatory control. The autophosphorylation of Thr-226, within the 
activation loop, is necessary for Atg1 kinase activity and the induction of autophagy. Thr-
226 is evolutionarily conserved in all Atg1 orthologs suggesting that this phosphorylation 
event may be an important point of regulation for this pathway in all eukaryotes. In 
addition, a recent mass spectrometry analysis of Atg1 performed in our lab has identified 
15 additional sites of phosphorylation within this protein. Given the complex regulation 
of the autophagy pathway and the importance of Atg1 for this control, we set out to 
characterize the potential regulatory roles of these Atg1 phosphorylation events.  Using 
site-directed mutageneses, we found that the alteration of most sites had only a modest 
effect upon the autophagy process. To regulate kinase activity and autophagy, multiple 




















Materials and Methods 




pPHY 1115 3xmyc-tagged Atg1 in pRS 316 generously provided by Dr. Ohsumi 
pPHY 1249 3x myc-tagged Atg1 in pRS 424 
pPHY 2622 Atg1 with T226E mutation in pRS 316, previously made from pPHY 
1115 
pPHY 2624 Atg1 with T226A mutation in pRS 316, previously made from pPHY 
1115 
pPHY 2792 Atg1 with S621A mutation in pRS 424, previously made from pPHY 
1249 
pPHY 2793 Atg1 with S677A mutation in pRS 426, previously made from pPHY 
1249 
pPHY 3514 Atg1 with S677A, and S683A mutations in pRS 316, previously 
made from pPHY 1115 
pPHY 3521 Atg1 with S621A, S677A, S683A mutations in pRS 316,  
pPHY 3528 Atg1 with S677A, S680A, S683A mutations in pRS 316, 
pPHY 3560 Atg1 with S365A mutation in pRS 316, made from pPHY 1115 
pPHY 3562 Atg1 with S680A mutation in pRS 316, made from pPHY 1115 
pPHY 3564 Atg1 with S683A mutation in pRS 316, made from pPHY 1115 
pPHY 3566 Atg1 with S769A mutation in pRS 316, made from pPHY 1115 
pPHY 3568 Atg1 with S783A mutation in pRS 316, made from pPHY 1115 
pPHY 3570 Atg1 with S621A mutation in pRS 316, subcloned from pPHY 2792 
into pPHY 1115 
pPHY 3572 Atg1 with S677A mutation in pRS 316, subcloned from pPHY 2793 




Strains and growth media: Standard E. coli growth conditions and media were used 
throughout this study. The yeast rich growth medium, YPAD, consists of 1% yeast extract, 
2% Bacto peptone, 500 mg/L adenine-HCl, and 2% glucose. The yeast YM glucose and SC 
glucose minimal growth media have been described (Kaiser et al. 1994). Growth media 
reagents were from DIFCO. The yeast strains used were PHY 2801 ( TN125 MATa ade2 
his3 leu2 lys2 trp1 ura3 pho8::pho8Δ60), PHY 2802 (YYK126 MATa ade2 his3 lys2 trp1 
ura3 pho8::pho8Δ60 atg1Δ::LEU2), PHY 4167 (BY 4741 MATa his3 leu2 met15 ura3 
atg1Δ::KANMX), PHY 4201 (BY 4741 MATa his3 leu2 met15 ura3 atg13Δ::KANMX), 
and PHY 4205 (BY 4741 MATa his3 leu2 met15 ura3 atg17Δ::KANMX) (Noda et al. 
1995; Kamada et al. 2000; Glaever et al.  2002). 
 
Mass Spectrometry analysis: Tandem MS/MS was performed on Atg1 protein in 
collaboration with Dr. Kay-Hooi Khoo in Academia Sinica, Taiwan. GST-tagged Atg1 
received from Dr. Mike Synder was grown in SC with 2% raffinose until OD600 0.6, and 
then induced with 3% galactose for 4 hours. The samples were run on SDS-gel, which 
was stained with G-250 commassie blue staining. The corresponding band of Atg1 was 
excised and sent to Taiwan. In brief, the protein sample was digested specifically at 
arginine and lysine by trypsin. The tryptic peptides were analyzed by MS and MS/MS 
approaches to determine the site of phosphorylation on Atg1. The composite of this 
analysis identified 15 phosphorylation sites with overall peptide coverage of 54% (Fig 5). 
 
Subcloning: Previously made mutations within Atg1 in high-copy plasmid (pPHY 1249) 
were subcloned out of Atg1 by PflMI and BglII and ligated into pPHY 1115. 
 10 
Gap repair to introduce a site-directed mutation: pPHY 1115 was linearized near 
amino acid 513 by a unique PshAI restriction digest. Standard PCR procedures were used. 
Reactions contained 200 µM dNTPs, 0.5 µM of each primer, 200 ng of template, 1x PCR 
reaction buffer and Taq polymerase.  One of the PCR primers for each site engineered the 
missense mutation to code for alanine at the site, and any synonymous mutation needed to 
create a new restriction site for subsequent screening. Cycling parameters were 94˚C for 2 
min, 25 cycles of 94˚C for 25s, 60˚C for 45s, and 72˚C for 8 min. The PCR products 
spanned the gap made by PshAI. 2.5 µg of the PCR product and 0.05 µg of linearized 
pPHY 1115 were transformed into PHY 2801 yeast cells. The cells were plated with Ura 
selection, and the resulting homologous recombined plasmid was extracted from yeast. 
The rescued plasmid was transformed into E. coli and restriction digestion specific to the 
mutation was used to screen for clones. Clones were purified by QIAGEN miniprep kit 
and DNA sequenced by the Ohio State University Plant-Microbe Genomics Facility. 
Further analysis of mutants was performed in PHY 2802 yeast cells. 
 
Western blotting: Protein samples for Western blotting were prepared by centrifuging 10 
ODs of cells (OD600 0.6-0.8) and they were resuspended in 200 µl of 2x urea sample 
buffer (8M urea, 40mM Tris, 10% β-Mercaproethanol, 6% SDS). The cells were vortexed 
with glass beads for 5 min at 4˚C, and then heated for 5 min at 65˚C. The cell extracts 
were centrifuged at 12,000 × g for 2 min and the protein extract was used for subsequent 
Western blotting.  The proteins were separated on SDS polyacrylamide gels, transferred to 
nitrocellulose membranes and the membranes were probed with the appropriate monoclonal 
primary (α-myc; Cell signaling) and secondary (α-mouse; GE Healthcare) antibodies. The 
Supersignal chemiluminescent substrate (Pierce) was used to detect the reactive bands. 
 11 
Autophagy assays: The alkaline phosphatase (ALP) based assay measures the delivery 
and subsequent activation in the vacuole of an altered form of the Pho8 alkaline 
phosphatase, known as Pho8Δ60 (Noda et al.  1995). The increase in alkaline 
phosphatase activity that was observed following the period of starvation or rapamycin 
treatment is a direct measure of the autophagy activity present in those cells. For the 
assays, the cells were resuspended in 300 µl of the assay buffer (250 mM Tris-SO4, pH 
9.4, 10 mM MgSO4, 10 µM ZnSO4) and then vortexed with glass beads. The cell lysates 
were clarified by centrifugation at 10,000 × g for 5 min, and 20 µl of the resulting protein 
extract was added to a tube containing 480 µl of assay buffer and 1.25 mg/ml solution of 
p-nitrophenylphosphate. This reaction mix was incubated for 30 min at 35 °C, and the 
reaction was then terminated by the addition of 500 µl of 2 M glycine-NaOH, pH 11. The 
absorbance at 405 nm of the resulting solution was then measured (Klionsky and Emr 
1989; Noda and Klionsky 2008). The protein concentrations in the cell extracts were 
determined with a bicinchoninic acid protein assay kit (Pierce). For the rapamycin 
experiments, autophagy assays were performed on cells that had been treated with 0.2 
µg/ml rapamycin for 4 h at 30°C. The relative level of autophagy was indicated by the 
difference in alkaline phosphatase activity detected between extracts prepared from log 
phase and rapamycin-treated cells. The data presented represent the average of at least 











Aim I: Importance of phosphorylation within the activation loop 
 
Atg1 kinase activity required phosphorylation at Thr 226 in the activation loop 
 A Western blot assay was used to determine Atg1 kinase activity in vivo. Kinase 
active Atg1 formed a second, slower migrating band (Atg1-P) under starvation conditions 
and rapamycin treatment. Inhibition of TOR signaling by the drug, rapamycin, has been 
shown to induce autophagy and mimic starvation conditions in yeast (Noda and Ohsumi 
1998.) The Atg1-P band is lost upon treatment with phosphatase, therefore is generated by 
phosphorylation on Atg1 (Stephan et al.  2009). A single phosphorylation site at Ser-390 
causes the shift to the upper band.  In addition, the Atg1-P band is absent when required 
components for Atg1 kinase activity like Atg13 or Atg17 are absent (Fig 1). The activation 
loop phosphorylation is a highly conserved regulatory mechanism for  certain kinases, and 
is required for a fully active kinase (Nolen et al. 2004). To assess the significance of 
phosphorylation in the activation loop of Atg1, we replaced the threonine at position 226 to 
alanine, a nonphosphorylatable amino acid (Atg1T226A).  This variant did not form a band in 
rapamycin conditions corresponding to Atg1-P (Fig. 2). This indicated that Atg1T226A lacks 
kinase activity, and that phosphorylation at T226 is important for the activation of Atg1 
kinase.  
 
T226A allele cannot induce autophagy 
 Since Atg1 kinase activity is required for the induction of autophagy, we wanted to 
test the kinase defective Atg1T226A for autophagy activity. For this purpose, we used an 
alkaline phosphatase (ALP) based assay. The ALP assay assesses the vacuolar delivery and 
processing of a truncated form of the Pho8 alkaline phosphatase, known as Pho8Δ60. This 
Pho8 variant lacks the targeting information necessary for its normal delivery to the vacuole 
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via the secretory pathway (Klionsky and Emr 1989; Noda et al.  1995). This altered protein 
can only be delivered to the vacuole by the autophagy pathway. Using this assay, Atg1T226A 
showed no significant induction of autophagy and was comparable to the kinase defective 
strain (D211A) or atg1Δ strain (Fig 3). These data indicate that phosphorylation within the 
activation loop is necessary for the induction of autophagy. 
 
T226E allele bypasses the need of Atg13 and Atg17 in autophosphorylation 
Phosphorylation at T226 is important for Atg1 kinase activity, so we mutated T226 
to either a glutamic acid or aspartic acid, phosphomimics. Atg1T226E forms Atg1-P in 
rapamycin treated cells as well as log phase cells (Fig. 4). Atg1T226E is a constituently active 
kinase, and we wanted to determine if Atg13 and Atg17 are still required for Atg1 kinase 
activity for this variant. The Atg1-P band formed in both atg13Δ and atg17Δ cells 
expressing the Atg1T226E variant demonstrating that the requirement of Atg13 and Atg17 
was bypassed (Fig 4). Together, these data suggest that phosphorylation at T226 is 
important for the activation of Atg1 kinase, and Atg13 and Atg17 are important for the 






























The loss of Atg1 autophosphorylation in vivo occurred in the absence of Atg13 or Atg17. 
Western blots were performed with extracts prepared from either log phase (L) or 









The presence of the T226A alteration resulted in a loss of Atg1 autophosphorylation in 
vivo. Western blots were performed with extracts prepared from either log phase (L) or 
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Autophagy activity was assessed with the ALP Pho8Δ60-based assay using an atg1Δ 
strain expressing the indicated Atg1 proteins. The atg1Δ control strain contained a vector 
plasmid. Extracts were prepared from cells that had been treated with 200 ng/ml 




























The requirement of Atg13 and Atg17 in Atg1 autophosphorylation is bypassed with the 
T226E altered Atg1 allele. Western blots were performed with extracts prepared from 
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Aim II: Examine the significance of other phosphorylation sites on Atg1 
Elevated Atg1 kinase activity with S683A single and S677,680,683A triple mutants 
 A mass spectrometry analysis identified 15 phosphorylation sites on Atg1 with an 
overall coverage of 54% (Fig 5). These sites represent a subset of the possible 
phosphorylation events in Atg1.  We individually mutated seven serine residues that were 
determined by MS to be phosphorylation sites (a list of the positions can be found in 
Table 2). Due to the proximity of certain sites, we constructed a triple mutant, 
Atg1S677,680,683A. Three phosphorylation sites, which had similar adjacent sequences, were 
combined to create a second triple mutant, Atg1S621,677,683A. To evaluate how these 
phosphorylation sites affect Atg1 kinase activity, we analyzed each of the mutants using 
the Western blot assay described previously. Most of the single serine-to-alanine mutants 
were similar to wild type Atg1 except for Atg1S683A. Atg1S683A and a triplet mutant 
Atg1S677,680,683A showed a stronger signal in the upper band, Atg1-P band, after rapamycin 
treatment (Fig 6). This modest increase of the Atg1-P band for the 2 mutants could 
demonstrate an increase in Atg1 kinase activity under rapamycin treatment conditions. 
 
Induction of autophagy was modestly decreased by a subset of mutants  
 We analyzed the serine-to-alanine mutants for the ability to induce autophagy. We 
used the alkaline phosphatase assay described above to investigate each mutant.  A subset of 
mutants showed a 30-40% decrease in autophagy activity including the triplet mutant 
Atg1S677,680,683A and a number of single serine-to-alanine mutations including at amino acid 
positions 365, 677, 769, and 783 (Fig 7). All other variants of Atg1 analyzed displayed 
similar induction of autophagy as wild type Atg1. None of the mutants showed a significant 
change in autophagy activity compared to wild type under normal growth conditions (data 
not shown). The modest decrease in the induction of autophagy of several of the mutants 
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studied indicates the possible need of multiple phosphorylations on Atg1 to affect the 
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Figure 6
Atg1 kinase activity increased in S683A and S677,680,683A mutants
The increased Atg1-P band in both Atg1S683A, and Atg1S677,680,683A indicates an increase in Atg1 kinase activity. Western blots were





























Autophagy activity was assessed with the ALP Pho8Δ60-based assay using an atg1Δ 
strain expressing the indicated Atg1 proteins. The atg1Δ control strain contained a vector 
plasmid. Extracts were prepared from cells that had been treated with 200ng/ml 
rapamycin for 4 h. The data shown are the average of at least three independent 






















Summary of Results 
Altered sites of 
phosphorylation 
Atg1 kinase activity Autophagy levels 
(% of wild type) 
S365A WT 65% 
S621A WT 100% 
S677A WT 68% 
S680A WT 100% 
S683A Increased Atg1-P band 100% 
S769A WT 61% 
S783A WT 53% 
S621A, S677A, S683A WT 100% 























 Autophagy has been implicated in a wide variety of diseases and has been 
suggested as a potential therapeutic target for many of these ailments (Levine and 
Kroemer 2008). For the purpose of utilizing autophagy as a therapeutic tool, it is vital 
that we develop a thorough understanding of how this pathway is regulated and 
controlled. Atg1 is a key regulator of autophagy and therefore a key target for 
manipulation in the pathway. The work here identifies a specific phosphorylation event 
within the activation loop of Atg1 as a potential point of control for autophagy in S. 
cerevisiae, and reveals more possible regulation events on Atg1. 
 The activation loop is a conserved domain within the kinase domain of many 
kinases. Phosphorylation within this loop permits appropriate binding of substrate with 
the kinase domain and/or facilitates the phosphorylation reaction (Johnson et al. 1996; 
Nolen et al. 2004). Phosphorylation within the activation loop of many protein kinases is 
required for their full activity and this can be an essential event for their activation (Nolen 
et al. 2004). We found that the ability to phosphorylate within the activation loop is 
necessary for Atg1 kinase activity. The presence of two previously-identified regulators 
of Atg1 kinase activity, Atg13 and Atg17, was required for this phosphorylation event. 
Interestingly, Atg1 no longer required the presence of Atg13 or Atg17 for 
autophosphorylation in vivo when T226 was replaced with a phosphomimetic, such as 
glutamic acid. Bypassing the necessity for these regulators suggests that one of the 
functions of the Atg13 and Atg17 proteins during autophagy is facilitating Atg1 
autophosphorylation within the activation loop. 
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 The MS analysis of Atg1 uncovered numerous potential phosphorylation sites 
within the protein. My work here found that no single phosphorylation site tested was 
absolutely necessary for Atg1 kinase activity or autophagy. However, many showed 
modest changes in either Atg1 kinase activity or autophagy. Single mutations may cause a 
conformational change within the C-terminal region of Atg1 and confer a slight decrease in 
binding affinity with partners for the necessary complex to induce autophagy. A subset of 
single phosphorylations analyzed was found to promote autophagy and dephosphorylation 
at Ser-683 increases Atg1 kinase activity. The S621,677,683A triplet allele showed normal 
induction of autophagy demonstrating that the S621A mutation suppresses the defect in 
autophagy seen with S677A allele. This leads us to believe that the regulation of Atg1 is 
complex and might require multiple phosphorylation events. The phosphorylations could 
work cooperatively, and many changes must be made to cause a complete change in 
autophagy or Atg1 kinase activity. Interestingly, one of the triple mutants, 
Atg1S677,680,683A, showed an increase in autophosphorylation, but impaired autophagy 
activity.  Additional analysis of these phosphorylation sites along Atg1 is needed to 
clarify the roles of these events and how they coordinate the activation of Atg1 with 
autophagy. In view of the fact that Atg1 and its regulators have been conserved through 
evolution, further analysis in budding yeast could help us gain valuable insights into the 
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